See What HealthDay Can Do For You
Contact Us

August 2008 Briefing - Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Lancet Supports WHO Report on Health Inequality

FRIDAY, Aug. 29 (HealthDay News) -- The final report by the World Health Organization's Commission on Social Determinants of Health contains a strong mandate for reducing global inequalities in health care, according to an editorial published in the Aug. 30 issue of The Lancet.

Full Text (subscription or payment may be required)
More Information

New Definition of Prostate Cancer Therapy Failure Examined

THURSDAY, Aug. 21 (HealthDay News) -- A new definition of biochemical failure after radiotherapy for prostate cancer overestimates recurrence-free survival and time to biochemical progression when applied after prostatectomy, according to a report in the August issue of Urology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Surgery for Urinary Tract Symptoms in Men Beneficial

THURSDAY, Aug. 21 (HealthDay News) -- Elderly men who have undergone transurethral resection of the prostate generally have long-term improvement in lower urinary tract symptoms, quality of life and satisfaction, researchers report in the August issue of Urology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Outlook Mixed on US Presidential Candidates' Health Plans

WEDNESDAY, Aug. 20 (HealthDay News) -- The health care plans proposed by John McCain and Barack Obama would have uncertain effects on health care coverage in America, but potential problems with each plan are evident, according to a perspective piece in the Aug. 21 issue of the New England Journal of Medicine.

Abstract
Full Text

Drug Effective for Kidney Stones in Resistant Patients

WEDNESDAY, Aug. 20 (HealthDay News) -- Acetazolamide is effective in treating kidney stones in patients who do not respond to potassium citrate and can tolerate the treatment, researchers report in the August issue of Urology.

Abstract
Full Text (subscription or payment may be required)

Tadalafil Offers Benefits for Benign Prostatic Hyperplasia

WEDNESDAY, Aug. 20 (HealthDay News) -- Daily treatment with tadalafil can relieve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH), according to research released online Aug. 19 in advance of publication in the October issue of the Journal of Urology.

Full Text

Seniors Likely to Find Medicare Health Web Site Unusable

TUESDAY, Aug. 19 (HealthDay News) -- Even older adults with computer skills may have difficulty using the Medicare.gov Web site to determine eligibility for services and enroll in a drug plan, according to a research letter published in the Aug. 20 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Urologist Caseload Volume May Affect Patient Outcome

TUESDAY, Aug. 19 (HealthDay News) -- Urologists who perform more transurethral resections of the prostate (TURP) may have lower rates of patient in-hospital mortality, according to an article published in the August issue of Urology.

Abstract
Full Text (subscription or payment may be required)

Manual Compression Decreases Cystoscopy Pain in Men

FRIDAY, Aug. 15 (HealthDay News) -- In men undergoing flexible cystoscopy, increasing hydrostatic pressure by simple manual compression of the irrigation solution bag ("bag squeeze") reduces procedural discomfort, according to a report in the August issue of Urology.

Abstract
Full Text (subscription or payment may be required)

ACE Inhibitor/ARB Combination Worsens Major Renal Outcomes

FRIDAY, Aug. 15 (HealthDay News) -- The combined use of the angiotensin converting enzyme (ACE) inhibitor ramipril and the angiotensin receptor blocker (ARB) telmisartan in patients with high cardiovascular risk is associated with worsened major renal outcomes compared to these drugs as monotherapy, researchers report in the Aug. 16 issue of The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial

Agent Orange Exposure Increases Prostate Cancer Risk

THURSDAY, Aug. 14 (HealthDay News) -- Agent Orange exposure among Vietnam veterans not only increases their risk of developing prostate cancer and development of more aggressive disease, but veterans are also diagnosed at a younger age, according to an article published in the Sept. 15 issue of Cancer.

Abstract
Full Text (subscription or payment may be required)

One-Fifth of Men Undergo Prostate Screening in Their 40s

THURSDAY, Aug. 14 (HealthDay News) -- One-fifth of men aged 40 to 49 in the United States report having a prostate-specific antigen (PSA) test within the last year, according to an article published online Aug. 11 in the journal Cancer.

Abstract
Full Text (subscription or payment may be required)

Nephrotic Syndrome Remission Linked to Improved Sodium

FRIDAY, Aug. 8 (HealthDay News) -- In patients who achieved remission of idiopathic membranous nephropathy (IMN) with rituximab, the remission was associated with improved sodium homeostasis and kidney hemodynamics, according to research published online Aug. 6 in the Clinical Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Expectant Management Best for Some Infertile Couples

FRIDAY, Aug. 8 (HealthDay News) -- In couples with unexplained infertility, treatment with either clomifene citrate or unstimulated intrauterine insemination does not result in superior live birth rates compared with expectant management, according to study findings published online Aug. 7 in BMJ Online First.

Abstract
Full Text
Editorial

Over 1 Billion U.S. Doctor, Hospital Visits Logged in 2006

THURSDAY, Aug. 7 (HealthDay News) -- In 2006, patients made an estimated 1.1 billion visits to physician offices and hospital emergency and outpatient departments in the United States, which was an average of four visits per person, according to health care statistics released Aug. 6 by the U.S. Centers for Disease Control and Prevention.

More Information

Combination Treatment Reduces Incontinence in Women

TUESDAY, Aug. 5 (HealthDay News) -- The addition of behavioral therapy to tolterodine treatment reduces incontinence in urge-incontinent women during active treatment only, according to a report in the Aug. 5 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

Prostate Cancer Screening Not Recommended Over Age 75

TUESDAY, Aug. 5 (HealthDay News) -- Men older than 75 years of age should not be screened for prostate cancer, and the benefits of screening are uncertain even in younger men, according to updated clinical guidelines published in the Aug. 5 issue of the Annals of Internal Medicine.

Abstract
Full Text

Region and Hospital Type Affect Prostate Cancer Care

MONDAY, Aug. 4 (HealthDay News) -- While there are significant differences in quality indicators related to prostate cancer care based on hospital type and U.S. region, there are no apparent racial differences, researchers report in the Aug. 1 issue of the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

International Issue of Torture Complicity Analyzed

FRIDAY, Aug. 1 (HealthDay News) -- More than 100 countries condone the use of torture and have often recruited the medical community as participants without consequence, according to an editorial published online July 31 in BMJ.

Editorial

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.